NRA Capital Pte Ltd

Written by: Jacky Lee

Thursday 28 May 2015

IPO watch - Singapore O&G Ltd

New healthcare play in growing market

The IPO price of S$0.25 translates to 13x FY14 historical PER and 4.5x PBR which seems attractive for a healthcare play. Given its zero debt and high cash flow generation with potential 7-8% dividend yield projected, we recommend to ...

Please login

Premium Content

Premium Content


This article requires a premium subscription. Click here to upgrade.

If you are not yet a registered member of NetResearch Asia, please click here to register before paying.

If you accessing this site though Lim&Tan's website and using Internet Explorer, please click here  to rectify access issues.


Access to this Web site is granted by NRA Capital Pte. Ltd. strictly on the terms and subject to the conditions set out hereunder. By entering into the Web Site, Subscriber is deemed to have accepted and agreed to be bound by the terms and conditions  set out hereunder.